Company intelligence / Profile preview

BlueHalo

Albuquerque, New Mexico, USAcm.hsvchamber.org ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

BlueHalo develops advanced biotechnology platforms—primarily fieldable biochemical sensors, wearable devices, smart medical apps, and data analytics tools—to improve warfighter and first responder readiness. Their solutions address operational medicine needs such as traumatic brain injury recovery, vestibular dysfunctions, environmental hazard detection via wearables/sensors/AI analytics. They do not have a pipeline of drugs but rather a suite of commercialized device/software platforms.

Therapeutic areas: OtherDermatologyNeurology
Modalities: DeviceSensor-based diagnosticsDigital health applicationsWearable electronics
Industry: Physiological Monitoring

Partnerships

US Department of Defense agencies including Air Force Research LaboratoryDefense Health Agency

Beyond the preview

Go deeper on BlueHalo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BlueHalo.

Explore the full profile